Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com, and follow us on X and Facebook.
We are fearless innovators united by a shared mission: To bring transformative therapies to people living with serious muscle diseases. We pursue our goals with passion, determination, agility and urgency, recognizing that countless lives are depending on our efforts. We are here to forever change lives. We know we will deliver.
We’re looking for colleagues who share this ethos to join the Dyne family. If you’re driven to deliver for people living with serious muscle diseases; if you put team and mission first; if you embrace bold ideas; if you are committed to accountability and transparency; if you have a drive to make a difference, we’d love to connect.
If you are a fearless innovator who embraces bold ideas, join our team of Dynamos on our mission to deliver life-transforming therapies to people with serious muscle diseases
Hear from our Dynamos
Our mission to bring life-transforming therapies to people with serious muscle diseases is the foundation of our efforts and is driven by our exceptional team of Dynamos and their dedication to fostering an unparalleled culture. Hear Dynamos share their perspectives on what makes Dyne a special place to work.
